Literature DB >> 8094115

Glucocorticoid exposure in utero: new model for adult hypertension.

R Benediktsson1, R S Lindsay, J Noble, J R Seckl, C R Edwards.   

Abstract

Hypertension is strongly predicted by the combination of low birthweight and a large placenta. This association could be due to increased fetal exposure to maternal glucocorticoids. Fetal protection is normally effected by placental 11 beta-hydroxysteroid dehydrogenase (11 beta-OHSD), which converts physiological glucocorticoids to inactive products. We found that rat placental 11 beta-OHSD activity correlated positively with term fetal weight and negatively with placental weight. Offspring of rats treated during pregnancy with dexamethasone (which is not metabolised by 11 beta-OHSD) had lower birthweights and higher blood pressure when adult than did offspring of control rats. Increased fetal glucocorticoid exposure secondary to attenuated placental 11 beta-OHSD activity may link low birthweight and high placental weight with hypertension.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8094115     DOI: 10.1016/0140-6736(93)90138-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  134 in total

Review 1.  The adrenal and the metabolic syndrome.

Authors:  M S Golub
Journal:  Curr Hypertens Rep       Date:  2001-04       Impact factor: 5.369

Review 2.  Antenatal treatment of a mother bearing a fetus with congenital adrenal hyperplasia.

Authors:  C G Brook
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-05       Impact factor: 5.747

Review 3.  The fetal and neonatal hypothalamic-pituitary-adrenal axis.

Authors:  P C Ng
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-05       Impact factor: 5.747

Review 4.  Programming of adrenocortical function and the fetal origins of adult disease.

Authors:  D I Phillips
Journal:  J Endocrinol Invest       Date:  2001-10       Impact factor: 4.256

Review 5.  Apparent mineralocorticoid excess syndromes.

Authors:  M Shimojo; P M Stewart
Journal:  J Endocrinol Invest       Date:  1995 Jul-Aug       Impact factor: 4.256

6.  The expression of Akt and ERK1/2 proteins decreased in dexamethasone-induced intrauterine growth restricted rat placental development.

Authors:  Asli Ozmen; Gozde Unek; Dijle Kipmen-Korgun; Emin Turkay Korgun
Journal:  J Mol Histol       Date:  2011-04-23       Impact factor: 2.611

7.  An inadequate glycaemic response to glucagon is linked to insulin resistance in preterm infants?

Authors:  L Jackson; A Burchell; A McGeechan; R Hume
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-01       Impact factor: 5.747

8.  Evidence that prenatal programming of hypertension by dietary protein deprivation is mediated by fetal glucocorticoid exposure.

Authors:  Sabeen Habib; Jyothsna Gattineni; Katherine Twombley; Michel Baum
Journal:  Am J Hypertens       Date:  2010-08-19       Impact factor: 2.689

9.  Fetal growth restriction and methylation of growth-related genes in the placenta.

Authors:  Xirong Xiao; Yan Zhao; Rong Jin; Jiao Chen; Xiu Wang; Andrea Baccarelli; Yunhui Zhang
Journal:  Epigenomics       Date:  2015-12-18       Impact factor: 4.778

Review 10.  Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease.

Authors:  Patrick W F Hadoke; Javaid Iqbal; Brian R Walker
Journal:  Br J Pharmacol       Date:  2009-02-23       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.